FAP and esophageal squamous cell carcinoma: SMA, FSP1, FAP, PDGFRα, and PDGFRβ were expressed in 82.8%, 72.4%, 61.2%, 88.8%, and 54.3% of stromal fibroblasts in patients with ESCC, respectively (Figure 2).